Natamycin 5% Eye Drops
Brand names: Natacyn
Natamycin 5% eye drops are a topical polyene antifungal suspension used to treat fungal keratitis and other fungal infections of the ocular surface, and are a first-line agent for filamentous fungal corneal infection such as Fusarium.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Natamycin binds ergosterol in the fungal cell membrane, disrupting membrane integrity and causing leakage of cellular contents and fungal cell death.
Prescribing in practice
- Suspected microbial keratitis is a sight-threatening emergency that should be managed under specialist ophthalmology supervision with corneal scrapes for microscopy and culture before or alongside starting treatment.
- Penetration into the cornea is limited and poor for deep or intraocular fungal disease, so it is most effective for surface and anterior corneal infection and may need to be combined with or switched to systemic or other antifungals.
- Shake the suspension well and continue for the full course directed, as fungal keratitis typically requires prolonged treatment with frequent early dosing.
Monitoring
Monitor by repeated slit-lamp examination of the corneal infiltrate and epithelial healing to confirm clinical response.
Counselling the patient
- Use the drops exactly as frequently as directed, including overnight if instructed early in treatment.
- Do not wear contact lenses while you have the infection or are using the drops.
- Attend all follow-up appointments, as fungal eye infections heal slowly and need close review.
Evidence & guidelines
Natamycin is an established first-line topical antifungal for filamentous fungal keratitis, supported by comparative trial evidence (the MUTT studies) favouring it for Fusarium keratitis.
Reference: RCOphth Microbial Keratitis Guidelines; Natacyn SPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme